Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer-Reference-Cited by-同舟云学术

Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer

Published:2018-09-24 Issue:6 Volume:144 Page:1453-1459
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hermans T.J.N.¹,Voskuilen C.S.¹^ORCID,Deelen M.¹,Mertens L.S.¹,Horenblas S.¹,Meijer R.P.¹²,Boormans J.L.³,Aben K.K.⁴⁵,van der Heijden M.S.⁶,Pos F.J.⁷,de Wit R.⁸,Beerepoot L.V.⁹,Verhoeven R.H.A.⁴,van Rhijn B.W.G.¹

Affiliation:

1. Department of Surgical Oncology, Division of Urology; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

2. Department of Urology; University Medical Center Utrecht; Utrecht The Netherlands

3. Department of Urology; Erasmus University Medical Centre; Rotterdam The Netherlands

4. Department of Research; Netherlands Comprehensive Cancer Organization; Utrecht The Netherlands

5. Department for Health Evidence; Radboud University Medical Centre; Nijmegen The Netherlands

6. Department of Medical Oncology; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

7. Department of Radiation Oncology; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

8. Department of Medical Oncology; Erasmus University Medical Centre; Rotterdam The Netherlands

9. Department of Medical Oncology; Elisabeth-TweeSteden Hospital; Tilburg The Netherlands

Funder

The Dutch Uro-Oncology Study Group

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31833/fullpdf

Reference26 articles.

1. Bladder carcinoma as a systemic disease;Prout;Cancer.,1979

2. Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale;Stein;BJU Int.,2006

3. Variations in pelvic lymph node dissection in invasive bladder cancer: a Dutch nationwide population-based study during centralization of care;Hermans;Urol Oncol.,2016

4. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Advanced Bladder Cancer Meta-analysis Collaboration;Eur Urol.,2005

5. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines;Witjes;Eur Urol.,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermediate term survival following open versus robot-assisted radical cystectomy in the Netherlands: results of the Cystectomie SNAPSHOT study;Tijdschrift voor Urologie;2023-11-13

2. New risk stratification for adjuvant nivolumab for high‐risk muscle‐invasive urothelial carcinoma;BJUI Compass;2023-10-27

3. Long-term survival after female pelvic organ-sparing radical cystectomy versus standard radical cystectomy: a multi-institutional propensity score-matched analysis;International Journal of Surgery;2023-06-16

4. Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer;World Journal of Urology;2023-05-31

5. The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?;Journal of Clinical Medicine;2023-05-09